Hematoporphyrin photoradiation therapy for intraocular and orbital malignant melanoma.

Abstract

Photoradiation therapy (PRT) is a new technique that is currently under investigation for the treatment of a variety of solid malignant tumors. The technique involves systemic administration of hematoporphyrin derivative (HpD), a photosensitizing compound that is preferentially retained by malignant cells and photoactivation of the neoplasm with red light (630 nm) to achieve selective destruction of cancer cells. We used HpD PRT for seven patients with malignant melanoma of the uvea and conclude that initial results of HpD PRT for uveal malignant melanoma are encouraging and justify further investigation.

Statistics

050100'87'90'93'96'99'02'05'08'11'14'17
Citations per Year

218 Citations

Semantic Scholar estimates that this publication has 218 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Tse1984HematoporphyrinPT, title={Hematoporphyrin photoradiation therapy for intraocular and orbital malignant melanoma.}, author={David T. Tse and Jonathan J. Dutton and Thomas Alan Weingeist and V M Hermsen and Robert C Kersten}, journal={Archives of ophthalmology}, year={1984}, volume={102 6}, pages={833-8} }